ALLMedicine™ Gastric Cancer Center
Research & Reviews 13,935 results
https://doi.org/10.1016/j.surg.2021.10.052
Surgery Lin HW, Loh EW et. al.
Dec 4th, 2021 - Omentectomy is conventionally performed in the procedure of gastrectomy for gastric cancer. However, the clinical value and importance of omentectomy remain unclear. This meta-analysis investigated the benefits and safety of gastrectomy with or wi...
https://doi.org/10.1038/s41556-021-00793-9
Nature Cell Biology; Fatehullah A, Terakado Y et. al.
Dec 4th, 2021 - Gastric cancer is among the most prevalent and deadliest of cancers globally. To derive mechanistic insight into the pathways governing this disease, we generated a Claudin18-IRES-CreERT2 allele to selectively drive conditional dysregulation of th...
https://doi.org/10.1016/j.clnesp.2021.09.005
Clinical Nutrition ESPEN; Lee DU, Fan GH et. al.
Dec 4th, 2021 - Malnutrition is a prominent feature of gastric cancer patients who suffer from gastric outlet obstruction, impaired peristalsis, and cancer-mediated disruptions in metabolic hemostasis. In this study, we systematically evaluate the impact of malnu...
https://doi.org/10.1186/s12885-021-09052-4 10.3322/caac.21492 10.3322/caac.21338 10.1016/S0140-6736(17)33326-3 10.1073/pnas.73.11.3852 10.1038/nature11993 10.1002/hep.29270 10.1016/j.cca.2015.02.018 10.1186/s12943-018-0935-5 10.18632/oncotarget.16681 10.1111/cpr.12277 10.1038/s41598-018-35806-5 10.1091/mbc.e08-06-0596 10.1016/j.molcel.2019.12.028 10.1016/j.canlet.2017.06.027 10.1002/jgm.3129 10.1016/j.cell.2009.01.002 10.1007/s12282-017-0793-9 10.15252/embr.201643581 10.1016/j.canlet.2019.11.038 10.1093/jb/mvy079 10.1186/s13578-018-0252-0 10.1186/s12943-017-0719-3 10.1186/s12943-019-0951-0 10.1016/j.omtn.2019.08.012 10.1186/s12943-019-1081-4 10.1186/s12943-019-1015-1 10.1038/ncomms14866 10.1172/JCI97325 10.1016/j.canlet.2015.03.001
BMC Cancer; Xu X, Wang S et. al.
Dec 4th, 2021 - The role of circular RNAs (circRNAs) in the occurrence and development of gastric cancer (GC) has recently attracted increasing interest. The following study investigates the role of a newly discovered hsa_circ_0008434, which has been confirmed to...
https://doi.org/10.1186/s13018-021-02809-4 10.1007/s40744-016-0046-y 10.1200/JCO.2014.59.4895 10.1007/s40744-016-0050-2 10.1038/bjc.2014.585 10.2174/1570163812666150602144310 10.2147/OTT.S119993 10.1016/j.nucmedbio.2016.07.008 10.1515/jtim-2017-0029 10.1016/j.gde.2017.11.007 10.1186/s12943-018-0934-6 10.1016/j.bbrc.2020.02.100 10.1016/j.lfs.2018.08.044 10.1016/j.brainres.2017.08.014 10.4161/15384047.2014.955442 10.1093/bmb/ldaa002 10.1093/bmb/ldz015 10.1093/bmb/ldaa040 10.2478/jtim-2019-0011
Journal of Orthopaedic Surgery and Research; Zhou J, Xu L et. al.
Dec 4th, 2021 - Circ-ATAD1 plays an oncogenic role in gastric cancer. However, its roles in other cancers are unclear. We aimed to analyze the role of circ-ATAD1 in osteosarcoma (OS). The expression levels of circ-ATAD1, mature miR-154-5p, and premature miR-154-5...
Guidelines 21 results
https://doi.org/10.1016/j.jacr.2021.08.006
Journal of the American College of Radiology : JACR; , Vij A et. al.
Nov 20th, 2021 - Epigastric pain can have multiple etiologies including myocardial infarction, pancreatitis, acute aortic syndromes, gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, and hiatal h...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116190
The Lancet. Oncology; Blair VR, McLeod M et. al.
Aug 8th, 2020 - Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is characterised by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is largely caused by inactivating germline mutations in the tumour...
https://doi.org/10.1097/AOG.0000000000003562
Obstetrics and Gynecology;
Nov 26th, 2019 - A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheri...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709778
Gut Banks M, Graham D et. al.
Jul 7th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...
https://doi.org/10.1038/ajg.2017.154
The American Journal of Gastroenterology; Moayyedi P, Lacy BE et. al.
Jun 21st, 2017 - We have updated both the American College of Gastroenterology (ACG) and the Canadian Association of Gastroenterology (CAG) guidelines on dyspepsia in a joint ACG/CAG dyspepsia guideline. We suggest that patients ≥60 years of age presenting with dy...
Drugs 2 results see all →
Clinicaltrials.gov 552 results
https://clinicaltrials.gov/ct2/show/NCT05143970
Dec 3rd, 2021 - CHANCES-IPC 2021-008 is First In Human, Phase I, multicenter, European study evaluating an anti-CD73, IPH5301 in advanced and/or metastatic cancer. The trial will be conducted in two parts, Part I- Dose escalation: This part aims to identify the m...
https://clinicaltrials.gov/ct2/show/NCT05143125
Dec 3rd, 2021 - Natural killer cells (NK cells) are derived from bone marrow lymphoid stem cells, which are a type of lymphocytes that can non-specifically kill tumor cells and virus-infected cells without pre-sensitization. NK cells can not only directly kill ma...
https://clinicaltrials.gov/ct2/show/NCT04443478
Dec 2nd, 2021 - Introduction: Lower mediastinal lymph node dissection has been adopted as standard by treatment guideline for adenocarcinoma of esophagogastric junction(AEJ), but the effect of laparoscopic mediastinal lymph node dissection remains unknown. The ai...
https://clinicaltrials.gov/ct2/show/NCT03713905
Dec 2nd, 2021 - Dose escalation study: Primary purpose: To investigate the safety and tolerability of GLS-010 in subjects with advanced solid tumors (mainly gastric cancer, esophageal cancer). Secondary purpose: 1. To characterize the pharmacokinetics(PK) profile...
https://clinicaltrials.gov/ct2/show/NCT04189445
Nov 30th, 2021 - Study TAS-120-202 is an open-label, multinational, 3-arm Phase 2 study evaluating the efficacy, safety, tolerability, PK, and pharmacodynamics of futibatinib in patients with FGFR aberrations. Eligible patients will be assigned to 1 of 3 treatment...
News 620 results
https://www.onclive.com/view/niraparib-demonstrates-pfs-benefit-in-chinese-population-with-advanced-ovarian-cancer
Nov 30th, 2021 - First-line maintenance treatment with the PARP inhibitor niraparib (Zejula) yielded a clinically meaningful and statistically significant improvement in progression-free survival (PFS) vs placebo in Chinese patients with platinum-responsive advanc...
https://www.onclive.com/view/hochster-shares-best-practices-on-molecular-markers-and-sequencing-in-gastric-cancer
Nov 29th, 2021 - For patients with gastric cancer, utilizing molecular markers and genomic profiling is becoming more crucial in guiding treatment decisions, according to Howard S. Hochster, MD. For patients with gastric cancer, immunotherapy has become part of...
https://www.onclive.com/view/ku-reviews-exciting-esmo-data-in-gastric-gej-cancer
Nov 15th, 2021 - Welcome to OncLive On Air®! I’m your host today, Jessica Hergert. OncLive On Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and...
https://www.onclive.com/view/esmo-2021-updates-in-gastroesophageal-and-gastric-adenocarcinomas
Nov 15th, 2021 - Data from the following clinical trials are discussed: LBA7 - Nivolumab (NIVO) plus chemotherapy (Chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcin...
https://www.medscape.com/viewarticle/962750
Nov 11th, 2021 - The risk of occult gastric adenocarcinoma is highly prevalent in hereditary lobular breast cancer (HLBC) families who harbor any type of CDH1 variant and this risk remains high in patients with no family history of gastric cancer, a prospective co...
